Codupha Central Pharmaceutical JSC

Codupha Central Pharmaceutical JSC EBITDA Margin

The EBITDA Margin of Codupha Central Pharmaceutical JSC (CDP.VN) as of Nov 3, 2026 is 2.32 %. In the previous year, EBITDA Margin was 1.76 % — a change of 31.24% (higher).

EBITDA Margin

2.32 %

YoY

31.24%

Last updated:

EBITDA Margin of Codupha Central Pharmaceutical JSC is 2024 2.32 % . EBITDA Margin of Codupha Central Pharmaceutical JSC was 2023 1.76 % . It decreases by 31.24% higher compared to the previous year.

The Codupha Central Pharmaceutical JSC EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2017
1.53 VND
Jan 1, 2018
1.81 VND
Jan 1, 2019
1.61 VND
Jan 1, 2020
2.42 VND
Jan 1, 2021
1.85 VND
Jan 1, 2022
1.79 VND
Jan 1, 2023
1.76 VND
Jan 1, 2024
2.32 VND
The Codupha Central Pharmaceutical JSC EBITDA Margin history
YEAREBITDA MarginYoY
2.32 %+31.24%
1.76 %-1.26%
1.79 %-3.56%
1.85 %-23.29%
2.42 %+49.81%
1.61 %-10.92%
1.81 %+18.55%
1.53 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Codupha Central Pharmaceutical JSC Stock analysis

What does Codupha Central Pharmaceutical JSC do? Codupha Central Pharmaceutical JSC, based in Ho Chi Minh City, Vietnam, manufactures and sells pharmaceutical products. The company offers warehouse systems, delivery services, distribution centers, and import/export services. Listed on 13 July 2018, it operates primarily within Vietnam's pharmaceutical sector, providing comprehensive supply chain solutions for its products. Codupha Central Pharmaceutical JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Codupha Central Pharmaceutical JSC stock

EBITDA Margin of Codupha Central Pharmaceutical JSC is 2.32 % in 2024.

EBITDA Margin of Codupha Central Pharmaceutical JSC changed from 1.76 % to 2.32 %, representing a 31.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Codupha Central Pharmaceutical JSC since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Codupha Central Pharmaceutical JSC with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Codupha Central Pharmaceutical JSC

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Codupha Central Pharmaceutical JSC